|
End-of-day quote
Shenzhen S.E.
20/08/2026
|
5-day change | 1st Jan Change | ||
| 8.700 CNY | +4.82% |
|
+0.93% | +9.57% |
| Market Cap | 5.06B 752M 644M 601M 552M 1.04B 71.99B 1.06B 7.13B 2.78B 36.08B 2.83B 2.76B 119B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.89B 727M 623M 581M 533M 1B 69.59B 1.02B 6.89B 2.69B 34.88B 2.73B 2.67B 115B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +4.82% | ||
| 1 week | +0.93% | ||
| Current month | +11.40% | ||
| 1 month | +11.83% | ||
| 3 months | -3.87% | ||
| 6 months | -13.09% | ||
| Current year | +9.57% |
| 1 week | 8.26 | 8.94 | |
| 1 month | 7.15 | 8.94 | |
| Current year | 7.08 | 11.38 | |
| 1 year | 7.08 | 11.38 | |
| 3 years | 3.58 | 11.98 | |
| 5 years | 3.58 | 11.98 | |
| 10 years | 3.58 | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 11/12/2017 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 01/08/2019 |
Sen Li
COO | Chief Operating Officer | 45 | 25/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 01/08/2019 |
Ying Yang
CHM | Chairman | 48 | 21/03/2019 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 21/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.82% | +0.93% | -22.74% | +34.88% | 717M | ||
| -2.58% | +3.05% | +76.62% | +126.51% | 1,141B | ||
| -1.88% | +2.25% | +49.84% | +60.13% | 659B | ||
| -1.65% | +4.09% | +24.83% | +73.87% | 470B | ||
| +1.20% | +2.62% | +41.69% | +46.21% | 366B | ||
| -0.61% | +2.10% | +23.43% | +40.38% | 302B | ||
| +0.32% | +3.25% | +0.94% | +13.25% | 254B | ||
| -2.16% | +3.40% | +45.73% | +65.72% | 239B | ||
| -1.10% | -0.70% | -14.31% | -53.04% | 207B | ||
| -2.30% | +4.57% | +21.66% | +90.22% | 183B | ||
| Average | -0.69% | +2.98% | +24.77% | +49.81% | 382.17B | |
| Weighted average by Cap. | -1.63% | +3.04% | +43.55% | +71.30% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 146M 125M 117M 107M 201M 13.99B 205M 1.39B 540M 7.01B 549M 537M 23.22B | 1.21B 179M 153M 143M 131M 247M 17.15B 252M 1.7B 662M 8.59B 673M 658M 28.45B |
| Net income | 13.65M 2.03M 1.74M 1.62M 1.49M 2.8M 194M 2.85M 19.24M 7.5M 97.33M 7.62M 7.46M 322M | 92.73M 13.79M 11.8M 11.01M 10.11M 18.99M 1.32B 19.36M 131M 50.94M 661M 51.77M 50.64M 2.19B |
| Net Debt | 189M 28.11M 24.07M 22.46M 20.61M 38.72M 2.69B 39.48M 266M 104M 1.35B 106M 103M 4.46B | -169M -25.1M -21.49M -20.05M -18.4M -34.57M -2.4B -35.25M -238M -92.72M -1.2B -94.24M -92.19M -3.98B |
Employees
1,188
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | CN¥8.700 | +4.82% | 34,083,990 |
| 19/08/26 | CN¥8.300 | -3.38% | 16,649,500 |
| 18/08/26 | CN¥8.590 | -1.38% | 15,169,100 |
| 17/08/26 | CN¥8.710 | -0.23% | 20,696,400 |
| 14/08/26 | CN¥8.730 | -0.23% | 22,324,100 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
















